Speakers

Sort by
Newest
Trending
1-30 of 58
Filter
Richard Sams
Scientific Director at KCA Laboratories
bioavailability, calibration, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis strain, certification, certified reference materials, chromatography, clinical trial, contamination, crystallization, delta-8-tetrahydrocannabinol, first pass effect, fume hood, good manufacturing practice, high-performance liquid chromatography, inductively coupled plasma mass spectrometry, institutional review board, iso/iec 17025, laboratory, laboratory glassware, lipophilicity, m&m's, mass spectrometry, measurement, natural product, nutraceutical, observational error, ph, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, pipette, ratio, reproducibility, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, thin-layer chromatography, truth, uncertainty, waters corporation
Priscilla Agoncillo
Co-Founder at Original Breeders League
anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis industry, democratic party (united states), dispensary, dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, food and drug administration, free market, gerrymandering, good manufacturing practice, hair loss, health care, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, mood stabilizer, neuroplasticity, neurotransmitter, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, selective serotonin reuptake inhibitor, sense, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression
Ryan Bellone
Commercial Director at KCA Labs
bioavailability, calibration, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis strain, certification, certified reference materials, chromatography, clinical trial, contamination, crystallization, delta-8-tetrahydrocannabinol, first pass effect, fume hood, good manufacturing practice, high-performance liquid chromatography, inductively coupled plasma mass spectrometry, institutional review board, iso/iec 17025, laboratory, laboratory glassware, lipophilicity, m&m's, mass spectrometry, measurement, natural product, nutraceutical, observational error, ph, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, pipette, ratio, reproducibility, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, thin-layer chromatography, truth, uncertainty, waters corporation
Alan Robinson
Co-Founder at Herbal Aspect
bioavailability, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis strain, clinical trial, delta-8-tetrahydrocannabinol, first pass effect, high-performance liquid chromatography, institutional review board, lipophilicity, mass spectrometry, natural product, nutraceutical, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, waters corporation
Daniel Sliva
CSO & Founder at DSTest Laboratories
allosteric regulation, anti-inflammatory, antiviral drug, aspirin, assay, attention, bioavailability, biology, blinded experiment, book, bootleg recording, brand, brand loyalty, breast cancer, cancer, cannabidiol, cannabidiol is, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cardiovascular disease, cell signaling, chemical substance, chemistry, chromatography, chronic pain, cigarette, clinical trial, clinicaltrials.gov, coffee, coffee bean, common sense, coronavirus disease 2019, crisis management, diesel fuel, dietary supplement, direct-to-consumer advertising, distillation, dose (biochemistry), drug, drug test, end-user, endocannabinoid system, experiment, first, pass effect, flax, food, food and drug administration, fraud, gastrointestinal tract, germination, good manufacturing practice, green tea, hemp, hepatotoxicity, high-performance liquid chromatography, hospital, ibuprofen, in vitro, infection, inflammation, innovation, insomnia, intravenous therapy, iso/iec 17025, knowledge, laboratory, ligand (biochemistry), lipid, marketplace, medication, melatonin, micro-encapsulation, mining, molecule, nabiximols, nanoparticle, national institutes of health, nutraceutical, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, organ transplantation, osteoarthritis, packaging and labeling, pain, paracetamol, peripheral neuropathy, petroleum, pharmaceutical industry, pharmacokinetics, pharmacology, psychoactive drug, randomized controlled trial, reason, receptor (biochemistry), recycling, reliability engineering, research, right to know, risk, route of administration, sense, serotonin, sleep disorder, social supports, steam distillation, steve jobs, supercritical fluid, taste, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, the end-user, thin-layer chromatography, toxicity, vitamin, warranty, waste, water, women's health
Dean Johnson
President at Applied Botanics
allosteric regulation, anti-inflammatory, antiviral drug, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, coronavirus disease 2019, flax, infection, insomnia, ligand (biochemistry), medication, melatonin, omega-3 fatty acid, omega-6 fatty acid, pharmacology, sense, sleep disorder, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin
Evan Ogburn
Founder at PHARM CBD
allosteric regulation, anti-inflammatory, antiviral drug, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, coronavirus disease 2019, flax, infection, insomnia, ligand (biochemistry), medication, melatonin, omega-3 fatty acid, omega-6 fatty acid, pharmacology, sense, sleep disorder, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin
Blair Curless
Clinical Pharmacist at Phoebe Putney Health System
absorption (pharmacology), advertising, analgesic, anti-inflammatory, aphria (company), bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, class action, coffee, cosmetics, damages, dietary supplement, distribution (marketing), doctor of pharmacy, dose (biochemistry), drug, euphoria, false advertising, federal trade commission, flavor, food, food and drug administration, hemp, interleukin 17, kool-aid, law, lawsuit, ligand (biochemistry), marketplace, medical cannabis, medication, mountain dew, nestea, new drug application, nonsteroidal anti-inflammatory drug, novel food, opioid, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, pricing, product testing, recycling, regulatory compliance, retail, route of administration, shelf life, social media, soft drink, sublingual administration, tea, tetrahydrocannabinol, tetrahydrocannabivarin, toast (honor), topical medication
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Najifa Choudhury
Ambulatory Care Pharmacist at PACE SEMI
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis (drug), cannabis edible, certificate of analysis, clinical trial, cytochrome p450, doctor of pharmacy, dose (biochemistry), drug interaction, drug overdose, euphoria, geriatrics, grapefruit–drug interactions, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, opioid, over-the-counter drug, oxycodone/paracetamol, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, prothrombin time, pulmonary embolism, route of administration, signal transduction, stroke, sublingual administration, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Eric Longo
CEO at Hemp Select
bioavailability, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis strain, clinical trial, delta-8-tetrahydrocannabinol, first pass effect, high-performance liquid chromatography, institutional review board, lipophilicity, mass spectrometry, natural product, nutraceutical, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, waters corporation
John MacKay
Founder at Synergistic Tech Research
accuracy and precision, acid, adenosine diphosphate, alkane, alpha-pinene, analytical chemistry, analytics, antioxidant, apple, assay, avery gilbert, bacteria, bioavailability, biofuel, biology, biotechnology, bit, blackberry, book, bootleg recording, botany, brand, brand loyalty, breakfast, breast cancer, brewery, butter, calibration, cancer, cannabidiol, cannabinoid, cannabinoid would be, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis sativa, cannabis smoking, cannabis strain, carbon dioxide, centrifuge, certificate of analysis, certification, certified reference materials, chemical compound, chemical equilibrium, chemical substance, chemist, chemistry, chromatography, cigarette, cis–trans isomerism, clinical trial, coconut oil, coffee, coffee preparation, colorado river, column chromatography, compliance training, contamination, conversation, countercurrent chromatography, court, crisis management, critical mass, crystal, crystallization, decaffeination, delta-8-tetrahydrocannabinol, diet (nutrition), dietary supplement, distillation, double bond, dynamic light scattering, eicosapentaenoic acid, electrical equipment in hazardous areas, electrospray ionization, elution, end-user, entourage effect, epilepsy, ethanol, evaporator, experiment, expert, extraction (chemistry), farmer, field of dreams, filtration, first pass effect, fish oil, food, fraud, frosted mini-wheats, fume hood, gas, gene, genetics, genomics, germination, good manufacturing practice, green tea, hashish, heat, hemp, herbal medicine, hexane, high-performance liquid chromatography, horticulture, humidity, hydrogen, hydrophile, inductively coupled plasma mass spectrometry, infection, information, institutional review board, inventory, iso/iec 17025, isomer, juice, knowledge, laboratory, laboratory glassware, laboratory., lecithin, light, lipophilicity, liquid, m&m's, macintosh, marketplace, mass spectrometry, measurement, medical cannabis, medical prescription, medication, membrane, mill (grinding), mining, mirror, mixture, molecular mass, molecule, motion, national institutes of health, natural product, nothing, nuclear magnetic resonance spectroscopy, nutraceutical, observational error, occupational safety and health, occupational safety and health administration, odor, oil refinery, omega-3 fatty acid, omega-6 fatty acid, ontario, orange juice, organic chemistry, organic compound, over-the-counter drug, oxygen, packaging and labeling, packaging, and labeling, paper chromatography, partition coefficient, password, personal protective equipment, pesticide, petroleum, ph, ph meter, pharmaceutical formulation, pharmacognosy, pharmacokinetics, pharmacology, pharmacy, pharmacy school, phase (matter), physics, pipette, plant, plumbing, potato, pre-medical, prescription drug, principal component analysis, question, rancidification, ratio, reason, recrystallization (chemistry), recycling, regulatory compliance, reliability engineering, reproducibility, research, right to know, risk, river, root, rotary evaporator, sampler (musical instrument), scattering, science, scientific community, scientific method, sedative, sesame, simulated moving bed, small molecule, sodium bicarbonate, solubility, solvent, spectroscopy, spectrum, star, starbucks, statistics, steel, steel-toe boot, stimulant, stove, subscription business model, supercritical fluid, supercritical fluid chromatography, supercritical fluid extraction, superheated water, synthetic cannabinoids, tax, technology, temperature, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, tetrahydrocannabinolic acid, tetrahydrocannabinolic acid synthase, tetrahydrocannabivarin, the end-user, the matrix, thermodynamics, thin-layer chromatography, time, tractor, tree, truth, ultraviolet, ultraviolet–visible spectroscopy, uncertainty, understanding, vitamin, vitamin c, vitamin e, vodka, warehouse, warranty, waste, water, waters corporation, wheat, yield (chemistry)
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Lola O Ohonba
Certified Medical Cannabist Specialist at WCI Health
absorption (pharmacology), alternative medicine, analgesic, anti-inflammatory, anti-predator adaptation, antidepressant, anxiolytic, appetite, bioavailability, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, democratic party (united states), doctor of pharmacy, dose (biochemistry), entourage effect, euphoria, food, food and drug administration, gerrymandering, interleukin 17, ligand (biochemistry), major depressive disorder, mechanism of action, medical cannabis, medication, neuroplasticity, neurotransmitter, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pain, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, red bull, route of administration, sense, serotonin, solvent, starbucks, sublingual administration, swing state, tetrahydrocannabinol, tetrahydrocannabivarin, topical medication
Thomas Howard
Co Host at Cannabis Legalization News
anti-inflammatory, antidepressant, anxiolytic, bank, bodyguard, brick and mortar, cannabidiol, cannabinoid, cannabis, cannabis (drug), credit card, crime, democratic party (united states), electronic cigarette, entourage effect, fence (criminal), financial crime, food and drug administration, gerrymandering, hsbc, jpmorgan chase, major depressive disorder, mastercard, mechanism of action, medical cannabis, medication, money laundering, neuroplasticity, neurotransmitter, paypal, pharmacology, post-traumatic stress disorder, price, psilocybin, psilocybin mushroom, psychedelic drug, sense, serotonin, suspicious activity report, swing state, tetrahydrocannabinol, underwriting, united states department of agriculture, united states postal service, visa inc.
Stephen Cutter
Founder & CEO at Hemp for the Future
allosteric regulation, anti-inflammatory, antiviral drug, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, coronavirus disease 2019, flax, infection, insomnia, ligand (biochemistry), medication, melatonin, omega-3 fatty acid, omega-6 fatty acid, pharmacology, sense, sleep disorder, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin
Joseph Friedman
Consultant, National Speaker, Medical Cannabis Pharmacist
absorption (pharmacology), analgesic, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis strain, clinical trial, delta-8-tetrahydrocannabinol, doctor of pharmacy, dose (biochemistry), euphoria, first pass effect, high-performance liquid chromatography, institutional review board, interleukin 17, ligand (biochemistry), lipophilicity, mass spectrometry, medication, natural product, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, route of administration, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, topical medication, waters corporation
Richard Harris
Founder at Great Health and Wellness
alzheimer's disease, antipsychotic, bipolar disorder, cannabidiol, cannabinoid, cannabis (drug), cannabis strain, certificate of analysis, depression (mood), dopamine, dose (biochemistry), emergency medical technician, hypertension, irritable bowel syndrome, medicine, norepinephrine, omega-6 fatty acid, paracetamol, parkinson's disease, pharmacology, placebo, post-traumatic stress disorder, prescription drug, serotonin, topical medication
Jorge A. Escudero
Pharmacist at CBD Apothecary
alzheimer's disease, antipsychotic, bipolar disorder, cannabidiol, cannabinoid, cannabis (drug), cannabis strain, certificate of analysis, depression (mood), dopamine, dose (biochemistry), emergency medical technician, hypertension, irritable bowel syndrome, medicine, norepinephrine, omega-6 fatty acid, paracetamol, parkinson's disease, pharmacology, placebo, post-traumatic stress disorder, prescription drug, serotonin, topical medication
Israel Garcia
Director Of Chemistry at Bayou City Hemp Company
bioavailability, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, emulsion, endocannabinoid system, food and drug administration, health, human, ibuprofen, memory, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, route of administration, shelf life, sleep, solution, tablet (pharmacy), tetrahydrocannabinol, transparency and translucency
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anticoagulant, antipsychotic, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, budtender, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, certificate of analysis, depression (mood), dispensary, dopamine, dose (biochemistry), dravet syndrome, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, fibromyalgia, food and drug administration, free market, good manufacturing practice, gpr55, hair loss, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medicine, mental disorder, mental health, methotrexate, morphine, norepinephrine, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, pharmaceutical industry, pharmacology, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, randomized controlled trial, rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, serotonin, spasticities, sports medicine, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vaporizer (inhalation device), warfarin
Mike Sandoval
President at Sante Laboratories
accuracy and precision, analytical chemistry, aspergillosis, bank, bioavailability, brand, breakfast, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemical substance, chemistry, competition, consumer protection, conversation, crystallization, cytochrome p450, diclofenac, dietary supplement, distillation, dose (biochemistry), dream, drug development, due diligence, electronic cigarette, emulsion, endocannabinoid system, experiment, expert, expungement, food and drug administration, frosted mini-wheats, health, human, humidity, ibuprofen, immunodeficiency, infection, information, insurance, investor, laboratory, loan, market (economics), medical cannabis, memory, mold, money, mycotoxin, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, ph meter, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, reason, regulatory compliance, route of administration, safety, scientific method, sesame, shelf life, sleep, solution, stove, tablet (pharmacy), technology, temperature, tetrahydrocannabinol, the matrix, traceability, tractor, transparency and translucency, treaty, understanding
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Randy Fink
Physician, Medical Director at Miami Center of Excellence, LLC
alternative medicine, anesthesia, antihypertensive drug, anxiety, arm, aromatherapy, bank, bioidentical hormone replacement therapy, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, cannabis sativa, clinical trial, crohn's disease, crop insurance, curriculum, depression (mood), diarrhea, dose (biochemistry), endocannabinoid system, entourage effect, erection, evidence-based medicine, finance, food and drug administration, gastrointestinal disease, general surgery, gums, hemp, human sexual activity, ileostomy, inflammatory bowel disease, libido, medical cannabis, medical prescription, medication, mind, organized crime, orgasm, pain management, payment, pharmaceutical industry, pharmacology, pharmacy, placebo-controlled study, prescription drug, psychoactive drug, retail, route of administration, tadalafil, terminal illness, tetrahydrocannabinol, therapeutic index, transgender hormone therapy (male-to-female), ulcerative colitis
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Sean Colvin
Senior Scientist at TreeHouse Biotech
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
1 2